The ERMA cohort comprises women aged 47 to 55 years living in the city of Jyväskylä and surrounding municipalities in Finland. The original invitation was posted to 82% of the cohort and 47% answered the invitation. The ...
Jun 12, 2018
0
0
(HealthDay)—Complete blood cell count parameters at commonly used or optimal thresholds do not offer high accuracy in identifying invasive bacterial infections (IBIs) in febrile infants (≤60 days of age), according to ...
Sep 12, 2017
0
117
A new study indicates that a classification system based on patient symptoms and basic lab tests can reduce the need for diagnostic imaging, hospital admissions, and surgery in patients with suspected appendicitis.
Jul 24, 2017
0
2
Imagine a day when you visit the doctor's office for your annual physical. Your physician orders routine tests - cholesterol, glucose and blood count - but they also order a sequence of your genome, all 3 billion letters ...
Jan 12, 2017
0
0
(HealthDay)—Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft-tissue sarcomas, cancers that develop in areas such as the muscles, fat, blood vessels and tendons.
Oct 19, 2016
0
0
Pneumonia is the most prevalent infection after open-heart surgery, leading to longer hospital stays and lower odds of survival.
Jul 26, 2016
0
3
The first clinical trial to test a newly approved breast cancer drug specifically in African American patients is now enrolling at Georgetown Lombardi Comprehensive Cancer Center and will begin soon at five other institutions ...
Jul 6, 2016
0
4
The chemotherapy treatments necessary to treat Acute Myeloid Leukemia (AML) in children can be grueling on the body, and can cause health-related complications during therapy, as well as long down the road after remission. ...
Jun 30, 2016
0
1
An Emory study published online this week in Circulation Research suggests that a disruption in the body's own regenerative capacity, measured by levels of circulating progenitor cells, may contribute to the development of ...
Jun 13, 2016
0
1
(HealthDay)—Venclexta (venetoclax) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia (CLL) characterized by a specific chromosomal abnormality called the 17p deletion.
Apr 11, 2016
0
0
